logo
Twitter
Discord
Email
logo
AMN Healthcare Services, Inc.

AMN Healthcare Services, Inc.

NYSE•AMN
CEO: Ms. Caroline Sullivan Grace
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 2001-11-13
AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.
Contact Information
8840 Cypress Waters Boulevard, Suite 300, Dallas, TX, 75019, United States
866-871-8519
www.amnhealthcare.com
Market Cap
$580.65M
P/E (TTM)
-2.1
16.2
Dividend Yield
--
52W High
$30.49
52W Low
$14.87
52W Range
2%
Rank26Top 9.6%
5.9
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.9 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$634.50M-7.71%
4-Quarter Trend

EPS

$0.76+322.22%
4-Quarter Trend

FCF

$14.76M-68.89%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Goodwill Impairment Loss Physician Solutions recorded $109.5M goodwill impairment loss due to lower volume and margin pressures in staffing segment.
Smart Square Sale Gain Recognized preliminary $39.2M gain from July 1, 2025 sale of Smart Square scheduling software business operations.
Nine Month Revenue Decline Total revenue fell 12% to $1,982.2M for nine months ended September 30, 2025, driven by Nurse Solutions.
Gross Margin Compression Noted Consolidated gross margin compressed to 29.2% from 31.1% due to higher provider pay packages and pricing pressure.

Risk Factors

Significant Net Loss Nine months resulted in net loss of $(88.0M) compared to $40.6M net income last year, reflecting impairments.
Staffing Volume Decreasing Travel nurse demand declined, impacting Nurse Solutions revenue, while language services pricing pressure continues.
Operating Cash Flow Down Net cash provided by operating activities decreased to $193.9M for nine months versus $247.6M prior year period.

Outlook

Debt Refinancing Completed Issued $400.0M 2031 Notes and amended credit facility; redeemed $500.0M 2027 Notes in October 2025.
Liquidity Sufficient Forecast Cash from operations and available credit expected to fund operations and liquidity requirements beyond the next 12 months.
Evolving Staffing Models Clients focus on permanent staff and alternative models, decreasing reliance on contingent labor post-pandemic environment.

Peer Comparison

Revenue (TTM)

AMN Healthcare Services, Inc.AMN
$2.72B
-11.4%
InnovAge Holding Corp.INNV
$863.43M
+9.8%
The Pennant Group, Inc.PNTG
$847.27M
+29.9%

Gross Margin (Latest Quarter)

Iovance Biotherapeutics, Inc.IOVA
97.9%
+65.9pp
Myriad Genetics, Inc.MYGN
69.9%
-0.3pp
Ginkgo Bioworks Holdings, Inc.DNA
67.0%
-21.7pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
PNTG$962.74M36.18.7%40.2%
MRVI$938.43M-4.1-42.6%4.2%
IOVA$835.86M-2.3-55.2%5.8%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-4.8%
Flat Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Feb 19, 2026
|
EPS:$0.22
|
Revenue:-
Reports
All Years

  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 7, 2025|
    Revenue: $634.50M-7.7%
    |
    EPS: $0.76+322.2%
    Beat

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 8, 2025|
    Revenue: $658.18M-11.1%
    |
    EPS: $-3.02-802.3%
    Miss

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 9, 2025|
    Revenue: $689.53M-16.0%
    |
    EPS: $-0.03-106.3%
    Miss

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 21, 2025|
    Revenue: $2.98B-21.3%
    |
    EPS: $-3.85-171.6%
    Miss

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 8, 2024|
    Revenue: $687.51M-19.4%
    |
    EPS: $0.18-87.1%
    Miss

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 9, 2024|
    Revenue: $740.69M-25.3%
    |
    EPS: $0.43-72.4%
    Miss

  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 10, 2024|
    Revenue: $820.88M-27.1%
    |
    EPS: $0.45-77.8%
    Miss

  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 22, 2024|
    Revenue: $3.79B-27.7%
    |
    EPS: $5.38-46.0%
    Beat